Should I buy or sell Kinnevik stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Kinnevik in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" KNKBF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KNKBF, but not buy additional shares or sell existing shares. View KNKBF analyst ratings or view top-rated stocks .

How have KNKBF shares performed in 2024?

Kinnevik's stock was trading at C$10.70 on January 1st, 2024. Since then, KNKBF shares have decreased by 5.6% and is now trading at C$10.11. View the best growth stocks for 2024 here .

Are investors shorting Kinnevik?

Kinnevik saw a drop in short interest in March. As of March 15th, there was short interest totaling 58,700 shares, a drop of 62.9% from the February 29th total of 158,200 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 587.0 days. View Kinnevik's Short Interest .

How do I buy shares of Kinnevik?

Shares of KNKBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:KNKBF

Kinnevik (KNKBF) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free KNKBF Stock Alerts

C$10.11

-1.15 (-10.22%)

(As of 04/18/2024 ET)

Compare

Today's Range: C$10.11
▼
C$10.11
50-Day Range: C$9.47
▼
C$11.99
52-Week Range: C$8.36
▼
C$16.00

Volume: 1,011 shs
Average Volume: 715 shs
Market Capitalization: N/A

P/E Ratio: 162.00
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Short Interest

Get Kinnevik alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About Kinnevik Stock (OTCMKTS:KNKBF)

Kinnevik AB is a venture capital firm specializing in investments in early to late venture and growth capital. The firm also prefers indirect investments in venture capital funds. It prefers to invest in digital consumer business, education, communication, e-commerce and marketplaces, entertainment, healthcare, and financial services but may also invest in other areas. The firm invests worldwide, especially in Europe with a focus on the Nordics, Latin America, Asia, Australia, Africa, and North America. The firm looks for disruptive, technology-enabled and value-added consumer services in developed and emerging markets. It takes an active role on the boards of its subsidiaries and associated companies. It acts as a long-term lead shareholder in large listed entities. Kinnevik AB was founded in 1936 and is based in Stockholm, Sweden and additional office in London, United Kingdom. Kinnevik AB formerly known as Investment AB Kinnevik.

KNKBF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

KNKBF Stock News Headlines

April 11, 2024 | americanbankingnews.com

Kinnevik (OTCMKTS:KNKBF) Shares Down 6.1%

See More Headlines

Receive KNKBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kinnevik and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Finance
Industry: Financial Conglomerates
Sub-Industry: N/A
Current Symbol: OTCMKTS:KNKBF
CUSIP: N/A
CIK: N/A
Web: www.kinnevik.com
Phone: 46-8-56-20-00-00
Fax: N/A
Employees: 45
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 180.52
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Georgi Ganev (Age 48)
Chief Executive Officer
Comp: $16.49M
Mr. Samuel Sjostrom (Age 37)
Chief Financial Officer
Ms. Tatiana Shalalvand (Age 37)
Investment Director
Mr. Mattias Andersson (Age 48)
General Counsel & Company Secretary
Ms. Torun Litzen (Age 57)
Director of Corporate Communications
Ms. Anna Stenberg (Age 45)
Chief People & Platform Officer
Mr. Mathew Joseph CPA (Age 45)
Sustainability Director
Mr. Akhil Chainwala (Age 36)
Investment Director and Venture & Growth Investor
Mr. Magnus Jakobson (Age 48)
Capital Markets Director
Mr. Andreas Bernstrom (Age 50)
Senior Investment Director

Key Competitors

View All Competitors

KNKBF Stock Analysis - Frequently Asked Questions

Should I buy or sell Kinnevik stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Kinnevik in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" KNKBF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KNKBF, but not buy additional shares or sell existing shares.
View KNKBF analyst ratings or view top-rated stocks.
How have KNKBF shares performed in 2024?: Kinnevik's stock was trading at C$10.70 on January 1st, 2024. Since then, KNKBF shares have decreased by 5.6% and is now trading at C$10.11.
View the best growth stocks for 2024 here.
Are investors shorting Kinnevik?: Kinnevik saw a drop in short interest in March. As of March 15th, there was short interest totaling 58,700 shares, a drop of 62.9% from the February 29th total of 158,200 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 587.0 days.
View Kinnevik's Short Interest.
How do I buy shares of Kinnevik?: Shares of KNKBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:KNKBF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial